NOVARTIS
Nilotinib-tasigna
“Nilotinib” is the Drug / Molecule content in “Tasigna”. Tasugna belongs to a class of medications called tyrosine kinase inhibitor. Tyrosine kinases are proteins that act as chemical messengers and stops cancer cells to grow.
Indication
Tasigna is used for the treatment of blood cancer called Philadelphia chromosome positive chronic myeloid leukemia (CML).
Note
Precaution
- Tasigna is a prescription drug and should be used under proper medical guidance and advice. Recommended for old patients.
- Contraindications include, hypokalaemia, hypomagnesaemia, pregnancy, planned pregnancy, lactation and galactose/lactose intolerance.
Updated On Nov 02, 2019 by Admin
Strength
150 mg, 200 mg
Packing
1 x 14 Capsules
Storage
Store at a room Temperature not exceeding 30 C
Was this page helpful?
Related Products
NATCO PHARMA LIMITED (INDIA)
Imatinib-veenat
CIPLA LTD. (INDIA)
Imatib
NOVARTIS
Glivec-veenat
CIPLA LTD.
Imatib
Most Viewed Products
CIPLA LTD. (INDIA)
Abiraterone acetate-xbira
NATCO PHARMA LIMITED (INDIA)
Bendamustine-bendit
CIPLA LTD. (INDIA)
Bicalutamide-cassotide
NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
NATCO PHARMA LIMITED (INDIA)
Erlonat
Biocon Limited
Everolimus-evertor
NATCO PHARMA LIMITED (INDIA)
Exemestane-xtane
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Glatiramer acetate-glatimer
NATCO PHARMA LIMITED (INDIA)
Ledipasvir & sofosbuvir-hepcinat lp
NATCO PHARMA LIMITED (INDIA)
Lenalidomide-lenalid
NATCO PHARMA LIMITED (INDIA)
Pomalidomide-pomalid
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
NATCO PHARMA LIMITED (INDIA)
Sorafenib-sorafenat
CIPLA LTD. (INDIA)